triamterene and hydrochlorothiazide
- Product NDC
- 50090-6736
- 11-digit product format
- 500906736
- Labeler code
- 50090
- Product ID
- 50090-6736_33ee2725-84e2-49fa-a0b4-ac4fcd1ec16f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- triamterene and hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA208360
- Marketing category
- ANDA
- Marketing start
- 2018-09-04
- Substance
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Active strength
- 50; 75 mg/1; mg/1
- Pharmacologic classes
- Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
| WS821Z52LQ | TRIAMTERENE | 396-01-0 | TRIAMTERENE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-6736-0 | 50090673600 | 30 TABLET in 1 BOTTLE (50090-6736-0) | 30 tablet | 2023-10-12 | No | No | Historical |
| 50090-6736-2 | 50090673602 | 100 TABLET in 1 BOTTLE (50090-6736-2) | 100 tablet | 2023-10-20 | No | No | Historical |
| 50090-6736-5 | 50090673605 | 90 TABLET in 1 BOTTLE (50090-6736-5) | 90 tablet | 2023-10-20 | No | No | Historical |